Pharma News

Boehringer Ingelheim today announced the presentation of several new post-hoc analyses from the TONADO^® 1&2 and OTEMTO^® 1&2 studies at the American College of CHEST Physicians Annual Meeting in Montreal. One analysis showed significant lung function improvement, as measured by FEV1 AUC0–3, with once daily Spiolto^® Respimat^® in COPD patients* across a range of age groups, including those over 65 years of age.¹ In addition, a second analysis indicated that Spiolto^® Respimat^® reduces the frequency of night-time rescue medication use, as measured by puffs needed per night² and these reductions were sustained for up to 52 weeks. In a third analysis the improvement of dyspnea (or shortness of breath), as measured by the Transition Dyspnea Index (TDI), was shown in COPD patients, compared to tiotropium, olodaterol and placebo.³

Dabur India on announced 18.7 percent increase in its net consolidated profit at Rs.341.1 crore for the quarter ended September 30 as against Rs.287.5 crore in the year-ago period.

 In order to make healthcare affordable in Africa, leaders from the continent on Wednesday called for more investment by the Indian government and private investors in Africa.

The Centre on Wednesday informed the Supreme Court that it was opposed to "commercial surrogacy" and was in the process of enacting a law to make it a punishable offence.

Non-life insurer Future Generali India Insurance Company Ltd. hopes to increase its retail health insurance business with its new product, a senior official said on Wednesday.

Increased use of certain medications commonly used to treat heartburn and acid reflux may have damaging effects on the kidneys, say researchers, including one of Indian-origin.

Even at low levels, a class of preservatives widely-used in consumer products like shampoos, cosmetics, body lotions, and sunscreens can contribute to development of breast cancer, suggests new research.

 In a first, researchers have found evidence that nasal treatment with oxytocin, synthetic hormone commonly used to induce labour in pregnant women, can improve social, emotional and behavioural issues among young children with autism.

Natco Pharma has launched the first licensed generic version of ledipasvir+sofosbuvir combination in Nepal, under its brand name Hepcinat LP.

[adsense:336x280:8701650588]

Max Healthcare (MHC) today announced a partnership with Smart Group wherein MHC would acquire 51% stake in Saket City Hospital Pvt. Ltd., from Smart Health City Pte Ltd, the Singapore based BK Modi Group company which manages and operates the Delhi based Saket City Hospital (SCH). The transaction is subject to confirmatory diligence, requisite regulatory approvals and other customary conditions.